Cerus Corporation

NASDAQ:CERS

Medical - Devices

Healthcare
$1.90 +2.92%

+$0.08 today

Market cap
$383.71M
Beta
1.77
P/E (TTM)
-53.8
EPS (TTM)
-$0.05
52W Low $1.15High $3.15

Volume 6.69M

Average 2.33M

Returns on capital

Cerus Corporation management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-24.3%

avg -75.9%

ROIC

-21.7%

avg -39.3%

ROA

-7.0%

avg -31.5%

Analysis

ROA is currently the strongest return metric at -7.0% versus its period average of -31.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

William Greenman

Executive Chairman of the BoardUSD 1.55M59——

Vivek K. Jayaraman

President, Chief Executive Officer & DirectorUSD 964.15K512.23M1.11%

Kevin D. Green

Vice President of Finance & Chief Financial OfficerUSD 831.57K54——

Richard J. Benjamin

Chief Medical OfficerUSD 792.71K66777.36K0.39%

Chrystal Jensen

Chief Legal Officer, General Counsel & SecretaryUSD 755.5K55936.66K0.47%

Christian Boutemy

VP & MD of Cerus International————

Bianca Vos

Vice President of Administration————

Lainie Corten

Vice President of Corporate Strategy, Planning & Communications————

Timothy J. Lee

Head of Investor Relation————

Nina Mufti

Senior Vice President of Research & Development————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 17, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

23

$3.21M

Net Transaction Value

−$3.21M

Net selling

Most Active

Jayaraman Vivek K

6 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 17, 26

Jensen Chrystal

Direct

Sell$89.5K
Jul 16, 26

Jayaraman Vivek K

Direct

Sell$52.7K
Jun 30, 26

Jayaraman Vivek K

Direct

Sell$124.7K
Jun 30, 26

Jensen Chrystal

Direct

Sell$71.6K
Jun 30, 26

Greenman William Mariner

Direct

Sell$299.9K
Jun 30, 26

Green Kevin Dennis

Direct

Sell$99.1K
Jun 9, 26

BJERKHOLT ERIC

Direct

Sell$53.2K
May 29, 26

Jayaraman Vivek K

Direct

Sell$50K
May 1, 26

Jayaraman Vivek K

Direct

Sell$50K
Mar 12, 26

Jayaraman Vivek K

Direct

Sell$273.8K

1–10 of 23

Summary

Insiders reported 0 buys worth $0.00 and 23 sells worth $3.21M over the last 12 months. That adds up to net selling of $3.21M. Jayaraman Vivek K was the most active insider with 6 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+8.4%
+12.2% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A —

Analysis

Recent growth has been strongest in Revenue at +8.4% over three years. Forward estimates point to Revenue at +12.2% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Cerus Corporation compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about CERS's management, answered from reported figures.

Who manages CERS?

Cerus Corporation (CERS) lists 10 active executives. The top listed executive is Richard J. Benjamin, Chief Medical Officer.

Are CERS insiders buying or selling?

Recent insider activity shows net selling of $3.05M.